CompletedNCT02167620
Metformin for Diabetes Risk in People With Serious Mental Illness
About this title
Read the official source — NCT02167620Placebo comparisonAges 17–45CanadaSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 17 years to 45 years.
- Listed locations
- TorontoSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateJune 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 35
- Sponsor
- Centre for Addiction and Mental Health
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Canada
- Age range
- From 17 Years to 45 Years
- Official registry ID
- NCT02167620
- Official title
Show the full official title
Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Toronto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Metformin and Placebo.
Who was this study for?
Listed age limits: 17 years to 45 years.
